Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/8/10 → 04/22/16 |
Funding
- Novartis Pharmaceuticals Corporation: $217,328.49
A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis
- Coyle, Patricia K (PI)
- Krupp, Lauren (CoPI)
- Patel, Yashma (CoPI)
- Perkins, Candice (CoPI)
Project: Research